<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Abnormal regional hypermethylation of the calcitonin gene can be detected in up to 95% of patients with <z:hpo ids='HP_0011009'>acute</z:hpo> nonlymphocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> (ANLL) </plain></SENT>
<SENT sid="1" pm="."><plain>We used a polymerase chain reaction (PCR) based assay to detect abnormal regional hypermethylation at this locus in patients with primary <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) </plain></SENT>
<SENT sid="2" pm="."><plain>Hypermethylation was detected in 13 of 20 patients (65%) with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and was detected in nine patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and <z:mpath ids='MPATH_458'>normal</z:mpath> cytogenetics </plain></SENT>
<SENT sid="3" pm="."><plain>There was no correlation between detection of this abnormality and the subtype of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Four of the 13 patients (30%) with abnormal methylation have progressed to ANLL with a median time to progression of 3.5 months </plain></SENT>
<SENT sid="5" pm="."><plain>The actuarial median survival of the cohort with abnormal methylation was 17 months, while that of the cohort with <z:mpath ids='MPATH_458'>normal</z:mpath> methylation is not yet reached </plain></SENT>
<SENT sid="6" pm="."><plain>These preliminary findings suggest that detection of abnormal methylation at this locus may be useful as a diagnostic tool in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Furthermore, hypermethylation of the calcitonin gene may be a poor prognostic feature that predicts progression to <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> in patients with primary <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
</text></document>